Ghent University Academic Bibliography

Your filters: cql: parent exact "BRITISH JOURNAL OF HAEMATOLOGY"

Add to list
- Conference Paper
- C3
Glofitamab in patients with heavily pretreated relapsed/refractory mantle cell lymphoma : phase I/II study subgroup results

Dr Toby Eyre, Tycel Phillips, Mark Trneny, Carmelo Carlo-Stella, Jan Zaucha, Tomasz Wrobel, Fritz Offner (UGent) , Michael Dickinson, Monica Tani, Michael Crump, et al.

(2025) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 206(Supplement 1). p.204-205
Add to list
- Conference Paper
- C3
Fixed-duration epcoritamab plus R-CHOP in newly diagnosed diffuse large B-cell lymphoma : EPCORE NHL-2 update

Lorenzo Falchi, Fritz Offner (UGent) , Sven de Vos, Joshua D. Brody, Raul Cordoba, Kim M. Linton, Sylvia Snauwaert, Michael Roost Clausen, Toshihiko Oki, Andrew J. Steele, et al.

(2025) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 206(Supplement 1). p.185-185
Add to list
- Conference Paper
- C3
Epcoritamab monotherapy in relapsed/refractory chronic lymphocytic leukemia : EPCORE CLL-1 expansion and optimization data

Ewan Robson, Alexey Danilov, Bita Fakhri, Farrukh Awan, Hans Herluf Bentzen, Herbert Eradat, Carsten Utoft Niemann, Fritz Offner (UGent) , Christian Bjorn Poulsen, Thor Hoyer, et al.

(2025) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 206(Supplement 1). p.382-383
Add to list
- Conference Paper
- C3
LOTIS-7 : phase 1b study of loncastuximab tesirine with other agents in relapsed/refractory B-cell NHL

Emily C. Ayers, Julien Depaus, Fritz Offner (UGent) , Marie Hu, Craig Okada, Andrzej Urban, Andrew Niewiarowski, Erica Rave, Mary Laughlin, Juan Pablo Alderuccio, et al.

(2025) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 206(Supplement 1). p.389-389
Add to list
- Journal Article
- A1
- open access
Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia

Lene Karlsson, Daniel Cheuk, Barbara De Moerloose (UGent) , Henrik Hasle, Kirsi Jahnukainen, Kristian Løvvik Juul‐Dam, Gertjan Kaspers, Zanna Kovalova, Birgitte Lausen, Ulrika Norén Nyström, et al.

(2023) BRITISH JOURNAL OF HAEMATOLOGY. 201(4). p.757-765
Add to list
- Conference Paper
- C3
CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment

Niels W. C. J. Van de Donk, Michel Delforge, Mounzer Agha, Adam D. Cohen, Yael C. Cohen, Jens Hillengass, Sebastien Anguille, Tessa Kerre (UGent) , Wilfried Roeloffzen, Jordan M. Schecter, et al.

(2022) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 197(supplement 1). p.118-119
Add to list
- Journal Article
- A1
- open access
Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies : a EuroFlow study

Martijn W. C. Verbeek, Chiara Buracchi, Anna Laqua, Stefan Nierkens, Lukasz Sedek, Juan Flores‐Montero, Mattias Hofmans (UGent) , Elaine Sobral de Costa, Michaela Nováková, Ester Mejstrikova, et al.

(2022) BRITISH JOURNAL OF HAEMATOLOGY. 197(1). p.76-81
Add to list
- Journal Article
- A1
- open access
Clinical outcomes of second relapsed and refractory first relapsed paediatric AML : a retrospective study within the NOPHO‐DB SHIP consortium

Tara White, Gertjan Kaspers, Jonas Abrahamsson, Nira Arad‐Cohen, Daniela Cianci, Jose Fernandez, Shau‐Yin Ha, Henrik Hasle, Barbara De Moerloose (UGent) , C. Michel Zwaan, et al.

(2022) BRITISH JOURNAL OF HAEMATOLOGY. 197(6). p.755-765
Add to list
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies

Albrecht Betrains, Laurent Godinas, F. J. Sherida H. Woei-A-Jin, Wouter Rosseels, Yannick Van Herck, Natalie Lorent, Daan Dierickx, Veerle Compernolle (UGent) , Geert Meyfroidt, Lore Vanderbeke, et al.

(2021) BRITISH JOURNAL OF HAEMATOLOGY. 192(6). p.1100-1105
Add to list
- Journal Article
- A1
- open access
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics

Simon J. Harrison, Aurore Perrot, Adrian Alegre, David Simpson, Ming Chung Wang, Andrew Spencer, Sosana Delimpasi, Cyrille Hulin, Kazutaka Sunami, Thierry Facon, et al.

(2021) BRITISH JOURNAL OF HAEMATOLOGY. 194(1). p.120-131

Academic Bibliography

Glofitamab in patients with heavily pretreated relapsed/refractory mantle cell lymphoma : phase I/II study subgroup results

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed diffuse large B-cell lymphoma : EPCORE NHL-2 update

Epcoritamab monotherapy in relapsed/refractory chronic lymphocytic leukemia : EPCORE CLL-1 expansion and optimization data

LOTIS-7 : phase 1b study of loncastuximab tesirine with other agents in relapsed/refractory B-cell NHL

Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia

CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies : a EuroFlow study

Clinical outcomes of second relapsed and refractory first relapsed paediatric AML : a retrospective study within the NOPHO‐DB SHIP consortium

Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies

Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics

Contents

Support

Contact